Expert Insights

Webinar: The Programmers Approach to Real World Data and Using Real World Evidence in Research and Healthcare

by MMS Holdings and MichBio.org
This webinar is intended to help guide individuals towards a better understanding of core concepts and requirements for using real-world data (RWD). Here, we will delve into how one can derive and utilize real-world evidence (RWE) in drug development, from the perspective of a clinical trial programmer/data analyst. We will discuss the potential opportunities that can generate RWD to improve the safety, efficiency, and quality in a clinical paradigm.

Pharmaceutical Industry News Roundup: September 2019

Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection of top stories to keep an eye on in September 2019: FDA Developing Guidance on Real-World Data Quality Issues, Officials Say.

Planning for Health Canada’s New Transparency Initiatives for Clinical Data

By Regina Parott, September 12, 2019
In March 2019, Health Canada created a new transparency requirement. Health Canada’s Public Release of Clinical Information (PRCI) states that their “objective is to make anonymized clinical information in drug submissions and medical device applications publicly available for non-commercial purposes following the completion of Health Canada’s regulatory review process, while adhering to Canada’s Privacy Act”.

Pharmaceutical Industry Experts Speak Out: Five Productivity Tips for Working from Home

By Don McLean, MBA, September 5, 2019
In the pharmaceutical industry, the right talent can often live in a variety of locations. When talking to our colleagues who have the privilege to work from home (WFH), we found that they are happy, productive, and active contributors to the workplace on a daily basis. According to an article on Inc.com, employee attrition decreases by 50 percent for those who work remotely and employees work a true full-shift, compared to those working in the office.

Using Real World Data in Drug Development: Five Questions with Vijay Ivaturi, PhD

by Staff Writer, August 22, 2019
The idea and practice of using real world data in the pharmaceutical industry has driven much conversation as of late. As groups like the Health Analytics Collective begin to bring game-changing methodologies to the marketplace, we sat down with Vijay Ivaturi, PhD, assistant professor at the University of Maryland School of Pharmacy and co-founder of the Collective, to get a sense of what the future holds.

Recommended Reading from Eight Pharmaceutical Experts This Summer

by Staff Writer, August 15, 2019
Summer reading isn’t reserved for school-aged children, as adults and professionals alike can gain knowledge and insights from consistently reading material during the hottest months of the year. With Book Lover’s Day last week, we asked eight colleagues from varying departments and levels within the organization to share what they’re reading this summer.

 

6880 Commerce Blvd.
Canton, MI 48187 USA
734.245.0310 T
734.245.0320 F

Email Us

FacebookLinkedIn

Learn more about working with MMS

9 + 11 =

© MMS Holdings Inc. All rights reserved. Privacy Policy